It’s only fair to share… Bevemipretide, CAS 2356106-71-1 FREE BASE CAS SBT-272 Trihydrochloride, 2589640-11-7 607.7 g/mol, C31H45N9O4 F553HAL9V8 Phase IAmyotrophic lateral sclerosis 18 Sep 2024Pharmacodynamics data from a preclinical trial in dry age related macular degenration released by Stealth BioTherapeutics The present technology relates generally to compounds (i.e. peptidomimetics), compositions (e.g. medicaments) and methods for treating, …